April 26 (Reuters) - Helius Medical Technologies Inc :
* Board says necessary to re-evaluate accounting relating to
warrants issued in private placements in april, june, july 2015
* Reclassification of 2015 warrants will not affect
company's balance sheet or liquidity
* Reclassification of 2015 warrants has resulted in a
reduction of comprehensive loss for period ending june 30, 2015
* Board says need to restate consolidated financial
statements for three months ended june 30, 2015, three months
and six months ended sept 30, 2015
* Reclassification of 2015 warrants had no impact on loss
per share for period ending december 31, 2015
* Reclassification of 2015 warrants has resulted in an
increase in diluted gain per share for period ending sept. 30,
2015
* Board says also need to restate consolidated financial
statements for three and nine months ended december 31, 2015
* Anticipates that it will file restated financial
statements covering restatement periods on or about april 26,
2016.
* Continuing to assess effect of restatement on assessment
of internal control over financial reporting,disclosure controls
* Restatement necessary as 2015 warrants, whose exercise
prices are denominated in usd although co's functional currency
is canadian dollar
Source text for Eikon:
Further company coverage: HSM.TO
(Bengaluru Newsroom: +1-646-223-8780)